| 1. |
Modification to recommended age of second MMR vaccine dose |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 2-2
&NA;,
Preview
|
PDF (826KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 2. |
Do hospital formularies need more than one quinolone? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 3-4
Alison Forbes,
Preview
|
PDF (1583KB)
|
|
摘要:
The answer for many hospitals is probably yes. There are now 4 generations of quinolones, with the agents of the third and fourth generations having extended spectra of activity compared with the earlier quinolones such as ciprofloxacin. The implications for hospitals with regard to the use of the new quinolones, both those that have been launched and those that will become available in the next few months, were discussed at the 32nd Annual Midyear Clinical Meeting of the American Society of Health-Systems Pharmacists (ASHP) [Atlanta, US; December 1997].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 3. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 4-4
&NA;,
Preview
|
PDF (751KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 4. |
Moxonidine in hypertensionan‘innovative therapeutic approach’ |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 5-5
&NA;,
Preview
|
PDF (738KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 5. |
Battling antibacterial resistanceguidelines for paediatric URTI |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 6-6
&NA;,
Preview
|
PDF (786KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 6. |
Irritable bowel syndrome not a major burden in the UK |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 7-7
&NA;,
Preview
|
PDF (710KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 7. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 8-8
&NA;,
Preview
|
PDF (677KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 8. |
More effective radioimmunotherapy on the way for NHL? |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 9-10
Larry Prescott,
Preview
|
PDF (1482KB)
|
|
摘要:
A unique new radioimmunotherapeutic conjugate,131I anti-B1 antibody [B1, ‘Bexxar’; Coulter Pharmaceuticals], appears to offer an effective, well tolerated, and less costly approach for the treatment of patients with low-grade, and transformed low-grade, B-cell non-Hodgkin's lymphoma (NHL). The latest developments with this targeted therapy approach were presented at the 39th Annual Meeting & Exposition of the American Society of Hematology [San Diego, US; December 1997].
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 9. |
News in brief … |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 10-10
&NA;,
Preview
|
PDF (755KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
| 10. |
Gene therapy shows promise in mouse model of SCID |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1121,
1998,
Page 11-11
&NA;,
Preview
|
PDF (714KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1998
数据来源: ADIS
|
首页
